Latest News

Vivet Therapeutics raises €37.5 million in Series A financing round
Vivet Therapeutics raises €37.5 million in Series A financing round
Vivet Therapeutics raises €37.5 million in Series A financing round to advance novel gene therapies for treating inherited metabolic diseases READ MORE
Vivet Annual Meeting in Washington DC
Vivet Annual Meeting in Washington DC
Vivet Therapeutics Announces Presentation at the Upcoming American Society For Gene And Cell Therapy (ASGCT) Annual Meeting in Washington DC READ MORE
FDA news : Cellular & Gene Therapy Guidances
FDA news : Cellular & Gene Therapy Guidances
A useful resource of Cellular & Gene Therapy Guidance Documents READ MORE
EMA News
EMA News
This section of the website provides information for companies and individuals involved in developing and marketing medicines for human use… READ MORE
Gene Therapy of Liver Diseases
Gene Therapy of Liver Diseases
In Europe, a disease is defined as rare when it affects fewer than one out of every 2,000 people. However,… READ MORE